Nutritional DisorderNCT04554082
Evaluation of Micronutrients in Obese Patients
An observational study of Nutritional Disorder, run by Alexandria University.
Trial summary
The aim of the study primarily was to investigate the value of zinc to copper ratio as possible biomarker of trace elements imbalance in morbidly obese subjects undergoing LSG. Secondly to correlate zinc to copper ratio with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic biomarkers. Read more about this study
- Who is it for?
- Ages 20 to 55 years
- Conditions the study is for
- Nutritional Disorder
- What is being tested?
- laparoscopic sleeve gastrectomy
- Type of treatment
- Surgery or procedure
- How many people
- 107 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2015to 1 Apr 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 55 years
- All sexes
- No healthy volunteers
- Adult
Study population: adult obese subjects with BMI above 40 both males and females presence of obesity comorbidities as hypertension, insulin resistance "type 2 DM" eligible for laporoscopic sleeve gatrectomy
Who may be able to join
- micronutrient deficiency in morbid obese subjects Adults.
- BMI above 40
- presence of comorbidities as hypertenion, DM, dislipidemia
Who cannot join
- all causes which might cause micronutrient deficiency as presence of gastroesophageal reflux
- all causes which may cause increase obesity "BMI" as hormonal disturbance ; hypothyroidism or cushing, females receiving contraceptive pills
About this study
Official title: Impact of Zinc to Copper Ratio and Lipocalin 2 in Obese Patients Undergoing Sleeve Gastrectomy.
The aim of the study primarily was to investigate the value of zinc to copper ratio as possible biomarker of trace elements imbalance in morbidly obese subjects undergoing LSG.
Secondly to correlate zinc to copper ratio with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic biomarkers.
Prospective study will be carried out on 120 morbidly obese adult subjects with a body mass index (BMI) score above 40 along with presence of obesity-related comorbidity. Investigations will be measured preoperative and 9 months postoperative after performing Laparoscopic sleeve gastrectomy; for Body mass index (BMI) and waist circumference. As well as for complete blood count and biochemical biomarkers as fasting blood glucose, lipid profile, serum iron and ferritin. Serum Ceruloplasmin, Zn and Cu levels, followed by calculation of zinc to copper ratio. CRP, serum insulin, serum leptin and lipocalin-2 (Lcn2) will be determined.
Read the detailed description
CONSORT 2010 Flow Diagram
Materials and methods:
Recruitment Morbidly obese subjects attending clinic at Surgery department for laparoscopic sleeve gastrectomy Alexandria University Hospitals.
Pre-assignment Details adult morbidly obese subjects were included age above 20 years, BMI above 40 Suffering from comorbidities as hypertension, DM, dyslipidemia. Assigned participants were clinically evaluated for comorbidities as hypertension, DM, dyslipidemia.
As well as signs of nutritional deficiency as anemia, brittle nails.
Group Information one group of participants eligible for laparoscopic sleeve gastrectomy were assigned according to their will to participate in study.
Period of evaluation:
First visit: preoperative for clinical assessment of participants, determine BMI and waist circumference and withdrawal of serum blood sample Second visit: within one month after surgery to make sure that no complication occurred after surgery.
Third visit: nine months postoperative for revaluation of participants, determine BMI and waist circumference, and withdrawal of a serum blood sample
Number of participants at initiating the period of study. They were 120 morbidly obese subjects. Number of participants at the end of the period of study. They were 107 subjects, 13 obese subject withdraw from study as they didn't come during follow up period after 9 months.
Participants according Sex (69 females, and 38 male), with the mean age of 41.6±8.9 years. The mean preoperative BMI was 47.43±5.4 kg/m2. Then, they were evaluated 9 months after LSG.
Preoperative and Postoperative Clinical characteristics and metabolic variables in studied subjects.
Preoperative 9 months postoperative P Body weight (Kg) 129.7 ± 12.1 93.4 ±13.6 0.0013* BMI (kg/m2) 47.43±5.4 35.7±3.8 0.0052* Waist circumference (cm) 130.00 ± 4.68 91.82 ± 3.73 0.001* Systolic BP (mmHg) 146.0±17.0 132.0±11.0 0.001* Total cholesterol (mmol/L) 5.85 ± 0.41 4.64 ± 0.31 0.035* Triglycerides (mmol/L) 2.20 ± 0.23 1.92 ± 0.24 0.106 HDL cholesterol (mmol/L) 1.23 ± 0.19 1.39 ± 0.2 0.041* LDL cholesterol (mmol/L) 3.37 ± 0.23 2.97 ± 0.21 0.022* HOMA-IR 2.64 ± 1.3 1.44 ± 0.81 0.013* S. Leptin (ng/ml) 102.87 ± 49.16 33.47 ±12.76 0.0001* CRP (mg/L) 8.4±5.91 3.2±2.98 0.001* Lipocalin 2 (µg/L) 107.24±36.8 51.6±12.73 0.001* Albumin (g/dl) 4.05±0.21 3.91±0.29 0.113
*Statistically significant at (p≤0.05).
Outcome measures:
primarily was to investigate the value of zinc to copper ratio as possible biomarker of TE imbalance in morbidly obese subjects undergoing LSG.
For detection of presence of micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight
Secondly to correlate it with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic markers prospectively.
As zinc to copper ratio is considered as biomarker of micronutrient status; therefore, correlate it with other biomarkers of inflammation (lipocalin 2) and other parameters as BMI, FBG to determine if micronutrient status improve after weight loss or not Time frame: 9 months.
Follow-up and outcome parameters:
All studied subjects will be followed up for early postoperative complications (within the first month) as Bleeding or Leak. Then they will be reviewed after 9 months postoperatively for assessment of anthropometric measurements, control of preoperative comorbidities, and manifestations of TE deficiencies (anemia, hair loss, teeth problems, edema. etc.).
Anthropometric parameters
Body mass index (BMI) and waist circumference will be measured preoperative and 9 months postoperative.
Biochemical parameters
Fasting blood samples will be collected from participants prior to surgery and nine months postoperative, after overnight fast and divided into two tubes; EDTA for complete blood count, the rest into plastic tubes and serum sample.
Serum glucose and Total cholesterol, HDL- cholesterol, LDL- cholesterol, and triglyceride, total protein and Albumin. Serum iron (Fe), and ferritin.
Serum insulin, Ceruloplasmin, Zn and Cu levels, CRP and lipocalin-2 (Lcn2) .
Statistical analysis
All data will be analyzed with Statistical Package for the Social Sciences version 20 software (SPSS, Inc., Chicago, IL). Results will be displayed as mean ± SD. Paired Student's t-test used to compare the data pre-operative and nine months postoperative. The chi-squared test used for category variables. Spearman correlation coefficient used to detect the correlation between different variables. Statistical correlations calculated by Pearson's correlation test. P < 0.05 is considered significant.
- Conditions
- Nutritional Disorder
- Being tested
- laparoscopic sleeve gastrectomy
- Keywords
- obesity, zinc, copper, lipocalin 2
- Medical subject headings
- Nutrition Disorders, Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
laparoscopic sleeve gastrectomyProcedure or surgery
bariatric surgery to loss weight
| Study group | Role | What they receive |
|---|---|---|
| Preoperative Clinical characteristics and metabolic biomarkers | BMI and biochemical parameters including trace elements in patients undergoing laparoscopic sleeve gastrectomy before surgery Receives: Procedure: laparoscopic sleeve gastrectomy | |
| 9 months' Postoperative metabolic biomarkers | BMI and biochemical parameters including trace elements in patients 9 months after laparoscopic sleeve gastrectomy Receives: Procedure: laparoscopic sleeve gastrectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluation of zinc to copper ratio as biomarker of micro-nutrient deficiency
detect if there are micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight
Measured: nine months
Secondary outcomes (1)
correlate zinc to copper ratio to lipocalin 2 and other metabolic biomarkers
zinc to copper ratio is considered as biomarker of micronutrient status; therefore, it is correlated it with BMI, other biomarkers of inflammation (lipocalin 2) and other parameters as BMI, FBG to determine if micronutrient status improve after weight loss or not
Measured: nine months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Sep 2020
- Study start1 Jan 2015
- Primary completion1 Jan 2020
- Study completion1 Apr 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Nutritional DisorderStudies of the same condition, open and under way.
- More trials run by Alexandria UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 107 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alexandria University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, hala mourad demerdash, Alexandria University
- Investigators
- Hala M Demerdash, MD, Principal investigator, Alexandria University Hospitals
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04554082
- Sponsor's protocol ID
- 0304707
- Other IDs
- 00018699, 00012098
- Status last verified
- Sep 2020
- First submitted
- 6 Sep 2020
- Last updated
- 18 Sep 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Yerlikaya FH, Toker A, Aribas A. Serum trace elements in obese women with or without diabetes. Indian J Med Res. 2013 Feb;137(2):339-45.
PubMed 23563378
Study at a glance
From the registry record, last updated by the sponsor on 18 Sep 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Zinc to Copper Ratio and Lipocalin 2 in Obese Patients Undergoing Sleeve Gastrectomy.
- ClinicalTrials.gov ID
- NCT04554082
- Acronym / sponsor ID
- 0304707
- Conditions
- Nutritional Disorder
- Keywords
- obesity, zinc, copper, lipocalin 2
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 107 participants (actual)
- Lead sponsor
- Alexandria UniversityUniversity, hospital or other
- Study start
- 1 Jan 2015 (actual)
- Primary completion
- 1 Jan 2020 (actual)
- Study completion
- 1 Apr 2020 (actual)
- First posted
- 18 Sep 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study primarily was to investigate the value of zinc to copper ratio as possible biomarker of trace elements imbalance in morbidly obese subjects undergoing LSG.
Secondly to correlate zinc to copper ratio with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic biomarkers.
Prospective study will be carried out on 120 morbidly obese adult subjects with a body mass index (BMI) score above 40 along with presence of obesity-related comorbidity. Investigations will be measured preoperative and 9 months postoperative after performing Laparoscopic sleeve gastrectomy; for Body mass index (BMI) and waist circumference. As well as for complete blood count and biochemical biomarkers as fasting blood glucose, lipid profile, serum iron and ferritin. Serum Ceruloplasmin, Zn and Cu levels, followed by calculation of zinc to copper ratio. CRP, serum insulin, serum leptin and lipocalin-2 (Lcn2) will be determined.
Detailed description
CONSORT 2010 Flow Diagram
Materials and methods:
Recruitment Morbidly obese subjects attending clinic at Surgery department for laparoscopic sleeve gastrectomy Alexandria University Hospitals.
Pre-assignment Details adult morbidly obese subjects were included age above 20 years, BMI above 40 Suffering from comorbidities as hypertension, DM, dyslipidemia. Assigned participants were clinically evaluated for comorbidities as hypertension, DM, dyslipidemia.
As well as signs of nutritional deficiency as anemia, brittle nails.
Group Information one group of participants eligible for laparoscopic sleeve gastrectomy were assigned according to their will to participate in study.
Period of evaluation:
First visit: preoperative for clinical assessment of participants, determine BMI and waist circumference and withdrawal of serum blood sample Second visit: within one month after surgery to make sure that no complication occurred after surgery.
Third visit: nine months postoperative for revaluation of participants, determine BMI and waist circumference, and withdrawal of a serum blood sample
Number of participants at initiating the period of study. They were 120 morbidly obese subjects. Number of participants at the end of the period of study. They were 107 subjects, 13 obese subject withdraw from study as they didn't come during follow up period after 9 months.
Participants according Sex (69 females, and 38 male), with the mean age of 41.6±8.9 years. The mean preoperative BMI was 47.43±5.4 kg/m2. Then, they were evaluated 9 months after LSG.
Preoperative and Postoperative Clinical characteristics and metabolic variables in studied subjects.
Preoperative 9 months postoperative P Body weight (Kg) 129.7 ± 12.1 93.4 ±13.6 0.0013* BMI (kg/m2) 47.43±5.4 35.7±3.8 0.0052* Waist circumference (cm) 130.00 ± 4.68 91.82 ± 3.73 0.001* Systolic BP (mmHg) 146.0±17.0 132.0±11.0 0.001* Total cholesterol (mmol/L) 5.85 ± 0.41 4.64 ± 0.31 0.035* Triglycerides (mmol/L) 2.20 ± 0.23 1.92 ± 0.24 0.106 HDL cholesterol (mmol/L) 1.23 ± 0.19 1.39 ± 0.2 0.041* LDL cholesterol (mmol/L) 3.37 ± 0.23 2.97 ± 0.21 0.022* HOMA-IR 2.64 ± 1.3 1.44 ± 0.81 0.013* S. Leptin (ng/ml) 102.87 ± 49.16 33.47 ±12.76 0.0001* CRP (mg/L) 8.4±5.91 3.2±2.98 0.001* Lipocalin 2 (µg/L) 107.24±36.8 51.6±12.73 0.001* Albumin (g/dl) 4.05±0.21 3.91±0.29 0.113
*Statistically significant at (p≤0.05).
Outcome measures:
primarily was to investigate the value of zinc to copper ratio as possible biomarker of TE imbalance in morbidly obese subjects undergoing LSG.
For detection of presence of micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight
Secondly to correlate it with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic markers prospectively.
As zinc to copper ratio is considered as biomarker of micronutrient status; therefore, correlate it with other biomarkers of inflammation (lipocalin 2) and other parameters as BMI, FBG to determine if micronutrient status improve after weight loss or not Time frame: 9 months.
Follow-up and outcome parameters:
All studied subjects will be followed up for early postoperative complications (within the first month) as Bleeding or Leak. Then they will be reviewed after 9 months postoperatively for assessment of anthropometric measurements, control of preoperative comorbidities, and manifestations of TE deficiencies (anemia, hair loss, teeth problems, edema. etc.).
Anthropometric parameters
Body mass index (BMI) and waist circumference will be measured preoperative and 9 months postoperative.
Biochemical parameters
Fasting blood samples will be collected from participants prior to surgery and nine months postoperative, after overnight fast and divided into two tubes; EDTA for complete blood count, the rest into plastic tubes and serum sample.
Serum glucose and Total cholesterol, HDL- cholesterol, LDL- cholesterol, and triglyceride, total protein and Albumin. Serum iron (Fe), and ferritin.
Serum insulin, Ceruloplasmin, Zn and Cu levels, CRP and lipocalin-2 (Lcn2) .
Statistical analysis
All data will be analyzed with Statistical Package for the Social Sciences version 20 software (SPSS, Inc., Chicago, IL). Results will be displayed as mean ± SD. Paired Student's t-test used to compare the data pre-operative and nine months postoperative. The chi-squared test used for category variables. Spearman correlation coefficient used to detect the correlation between different variables. Statistical correlations calculated by Pearson's correlation test. P < 0.05 is considered significant.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Preoperative Clinical characteristics and metabolic biomarkers | – | Procedure: laparoscopic sleeve gastrectomyBMI and biochemical parameters including trace elements in patients undergoing laparoscopic sleeve gastrectomy before surgery |
| 9 months' Postoperative metabolic biomarkers | – | Procedure: laparoscopic sleeve gastrectomyBMI and biochemical parameters including trace elements in patients 9 months after laparoscopic sleeve gastrectomy |
Who may qualify
- Ages
- 20 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- adult obese subjects with BMI above 40 both males and females presence of obesity comorbidities as hypertension, insulin resistance "type 2 DM" eligible for laporoscopic sleeve gatrectomy
Key inclusion criteria (3 listed)
- micronutrient deficiency in morbid obese subjects Adults.
- BMI above 40
- presence of comorbidities as hypertenion, DM, dislipidemia
Key exclusion criteria (2 listed)
- all causes which might cause micronutrient deficiency as presence of gastroesophageal reflux
- all causes which may cause increase obesity "BMI" as hormonal disturbance ; hypothyroidism or cushing, females receiving contraceptive pills
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| laparoscopic sleeve gastrectomybariatric surgery to loss weight | Procedure or surgery | 9 months' Postoperative metabolic biomarkers, Preoperative Clinical characteristics and metabolic biomarkers |
Primary outcome
Evaluation of zinc to copper ratio as biomarker of micro-nutrient deficiency
Time frame: nine months
detect if there are micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight
1 secondary outcome
correlate zinc to copper ratio to lipocalin 2 and other metabolic biomarkers
Time frame: nine months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Sep 2020.
- Background: PubMed 23563378Yerlikaya FH, Toker A, Aribas A. Serum trace elements in obese women with or without diabetes. Indian J Med Res. 2013 Feb;137(2):339-45.
- Individual participant dataSharing planned: No
Related trials for Nutritional Disorder
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hala M Demerdash, MD principal investigator
Alexandria University Hospitals
Questions about this trial
What is this clinical trial studying?
An observational study of Nutritional Disorder, run by Alexandria University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluation of zinc to copper ratio as biomarker of micro-nutrient deficiency (time frame: nine months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04554082, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2020.